Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ruxolitinib cream may help treat severe hair loss in children.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

High-dose ciclosporin significantly improved a young cat's severe skin condition.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.